Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finding the Optimal Dose of Rivaroxaban in Hemodialysis Patients
NCT02047006Phase 4Completed
- Sponsor
- AZ Sint-Jan Brugge
- Start
- Sep 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in deep vein thrombosis (DVT), sponsored by AZ Sint-Jan Brugge. Started Sep 2013; status: completed.
02
Drugs
rivaroxaban
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT02047006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02047006.